Automate Your Wheel Strategy on CAH
With Tiblio's Option Bot, you can configure your own wheel strategy including CAH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CAH
- Rev/Share 984.4958
- Book/Share -11.4748
- PB -18.0215
- Debt/Equity -3.1372
- CurrentRatio 0.957
- ROIC 0.1177
- MktCap 51795719156.0
- FreeCF/Share 18.7059
- PFCF 11.6343
- PE 32.5292
- Debt/Assets 0.1635
- DivYield 0.0093
- ROE -0.55
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 2
- DCF Score 4
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | CAH | Citigroup | Neutral | Buy | -- | -- | Jan. 9, 2026 |
| Initiation | CAH | Barclays | -- | Overweight | -- | $243 | Dec. 9, 2025 |
| Upgrade | CAH | Wells Fargo | Equal Weight | Overweight | -- | $179 | June 3, 2025 |
| Upgrade | CAH | Jefferies | Hold | Buy | $140 | $150 | Feb. 5, 2025 |
| Upgrade | CAH | TD Cowen | Hold | Buy | $130 | $144 | Jan. 8, 2025 |
| Upgrade | CAH | Evercore ISI | In-line | Outperform | -- | $140 | Jan. 7, 2025 |
| Upgrade | CAH | BofA Securities | Neutral | Buy | $132 | $145 | Jan. 6, 2025 |
| Upgrade | CAH | Wells Fargo | Underweight | Equal Weight | $101 | $127 | Dec. 13, 2024 |
| Resumed | CAH | Mizuho | -- | Outperform | -- | $139 | Dec. 4, 2024 |
News
Pharma, Specialty Units Likely to Drive Cardinal Health's Q2 Earnings
Published: February 04, 2026 by: Zacks Investment Research
Sentiment: Positive
Cardinal Health's second-quarter earnings might have been driven by Pharma and Specialty Solutions, as strong utilization and GLP-1 momentum must have raised revenues and EPS.
Read More
Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?
Published: February 03, 2026 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read More
Cardinal (CAH) is an Incredible Growth Stock: 3 Reasons Why
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.
Read More
Cardinal (CAH) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Positive
Besides Wall Street's top-and-bottom-line estimates for Cardinal (CAH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.
Read More
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Positive
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Read More
4 Defensive Stocks to Buy as Consumer Confidence Dips to12-Year Low
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Positive
With consumer confidence at a 12-year low, low-beta picks AEE, FTS, CAH and JJSF stand out as defensive plays to weather volatility.
Read More
4 Stocks With Strong Coverage Ratios to Buy in a Tight Market
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Positive
CASY, CAH, EAT and FLS stand out with strong interest coverage ratios as investors seek stability in a tighter market.
Read More
5 Broker-Loved Stocks to Watch Amid Steady Start to Q4 Earnings Season
Published: January 29, 2026 by: Zacks Investment Research
Sentiment: Positive
As inflation cools and Q4 earnings season shows strength, brokers back stocks like CAH, AN, TGT, AVT and ABM for potential upside.
Read More
Cardinal Health (CAH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Published: January 29, 2026 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Is Cardinal Health (CAH) Stock Undervalued Right Now?
Published: January 28, 2026 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Here's Why Cardinal Health (CAH) is a Strong Growth Stock
Published: January 27, 2026 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy?
Published: January 23, 2026 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Cardinal Health Upgraded As It Maintains Investment-Grade Status And Position In Radiopharmaceuticals
Published: January 23, 2026 by: Seeking Alpha
Sentiment: Positive
Cardinal Health gets upgraded to a buy, despite its price having gone up over 100% since my bullish call in early 2024. CAH could benefit from longer-term macro demand for medical supplies, mitigating near-term provider margin pressures. Recent growth drivers include positive FY26 guidance, the Solaris Health acquisition, innovative product launches, and advances in nuclear medicine mentioned in the article.
Read More
4 Medical Supply Stocks Poised to Gain in a Prospering Industry
Published: January 22, 2026 by: Zacks Investment Research
Sentiment: Neutral
Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and ALGN.
Read More
Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?
Published: January 16, 2026 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read More
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Published: January 16, 2026 by: Zacks Investment Research
Sentiment: Positive
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Read More
3 Reasons Why Growth Investors Shouldn't Overlook Cardinal (CAH)
Published: January 15, 2026 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
Will Cardinal (CAH) Beat Estimates Again in Its Next Earnings Report?
Published: January 15, 2026 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: January 15, 2026 by: Zacks Investment Research
Sentiment: Positive
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Read More
5 Broker-Friendly Stocks to Keep an Eye on as Inflation Concerns Ease
Published: January 15, 2026 by: Zacks Investment Research
Sentiment: Positive
As inflation cools and earnings momentum builds, brokers are backing stocks like CAH, AN, AAL, ARCB and ABG for potential upside.
Read More
Cardinal Health, Inc. (CAH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Published: January 13, 2026 by: Seeking Alpha
Sentiment: Neutral
Cardinal Health, Inc. (CAH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Read More
Should Value Investors Buy Cardinal Health (CAH) Stock?
Published: January 12, 2026 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Buy These 5 Dividend Growth Stocks Amid Conflicting Labor Market Data
Published: January 12, 2026 by: Zacks Investment Research
Sentiment: Positive
Dividend-growth stocks like CAH stand out as labor data sends mixed signals, offering income stability and growth amid economic uncertainty.
Read More
Why Cardinal Health (CAH) is a Top Growth Stock for the Long-Term
Published: January 09, 2026 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
3 MedTech Stocks That Crushed the S&P 500 Over the Past Year
Published: January 09, 2026 by: Zacks Investment Research
Sentiment: Positive
TransMedics, KORU Medical Systems and Cardinal Health beat the S&P 500 as execution, earnings visibility and company-specific catalysts drove gains.
Read More
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Published: January 07, 2026 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Best Dividend Aristocrats For January 2026
Published: December 31, 2025 by: Seeking Alpha
Sentiment: Positive
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) underperformed SPY in 2025, gaining 7.2% versus SPY's 18.42%. Despite average underperformance, select Aristocrats like CAH (+74.18%), ALB (+66.90%), and CHRW (+61.22%) delivered strong double-digit returns. Dividend growth for the Aristocrats slowed to 5.52% in 2025, down from 5.78% in 2024, with 68 of 69 raising payouts.
Read More
4 Stocks With Solid Interest Coverage to Navigate the 2026 Market
Published: December 30, 2025 by: Zacks Investment Research
Sentiment: Positive
AMZN, CAH, LRN and EAT stand out with strong interest coverage ratios to help weather 2026's shifting market tides.
Read More
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
Published: December 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
4 Large-Cap MedTech Stocks to Keep Winning Streaks Alive in 2026
Published: December 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Four large-cap MedTech leaders, MDT, ISRG, CAH, EW, appear well-positioned to extend their winning streaks in 2026 on resilient procedure demand and innovation.
Read More
About Cardinal Health, Inc. (CAH)
- IPO Date 1983-08-04
- Website https://www.cardinalhealth.com
- Industry Medical - Distribution
- CEO Jason Hollar
- Employees 47922